Neonatal jaundice overview: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{ {{CMG}} ==Overview== '''Neonatal jaundice''' is a yellowing of the skin and other tissues of a newborn infant caused by increased levels of [[bilirubin]...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{
{{Neonatal jaundice}}


{{CMG}}
{{CMG}}


==Overview==
==Overview==
'''Neonatal jaundice''' is a yellowing of the [[skin]] and other tissues of a newborn [[infant]] caused by increased levels of [[bilirubin]]in the [[blood]].
''' Neonatal jaundice ''' is a yellowing of the [[skin]] and other tissues of a newborn [[infant]] caused by increased levels of [[bilirubin]]in the [[blood]].


A [[bilirubin]] level of more than 85 umol/l (5 mg/dL) manifests clinical [[jaundice]] in [[neonates]] whereas in adults a level of 34 umol/l (2 mg/dL) would look [[icteric]]. In newborns jaundice is detected by blanching the skin with digital pressure so that it reveals underlying skin and subcutaneous tissue.  Jaundice newborns have an apparent icteric [[sclera]], and yellowing of the face, extending down onto the chest.
A [[bilirubin]] level of more than 85 umol/l (5 mg/dL) manifests clinical [[jaundice]] in [[neonates]] whereas in adults a level of 34 umol/l (2 mg/dL) would look [[icteric]]. In newborns jaundice is detected by blanching the skin with digital pressure so that it reveals underlying skin and subcutaneous tissue.  Jaundice newborns have an apparent icteric [[sclera]], and yellowing of the face, extending down onto the chest.

Revision as of 16:15, 21 September 2012

Neonatal jaundice Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neonatal jaundice from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neonatal jaundice overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neonatal jaundice overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neonatal jaundice overview

on Neonatal jaundice overview

Neonatal jaundice overview in the news

Blogs on Neonatal jaundice overview

Directions to Hospitals Treating Neonatal jaundice

Risk calculators and risk factors for Neonatal jaundice overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Neonatal jaundice is a yellowing of the skin and other tissues of a newborn infant caused by increased levels of bilirubinin the blood.

A bilirubin level of more than 85 umol/l (5 mg/dL) manifests clinical jaundice in neonates whereas in adults a level of 34 umol/l (2 mg/dL) would look icteric. In newborns jaundice is detected by blanching the skin with digital pressure so that it reveals underlying skin and subcutaneous tissue. Jaundice newborns have an apparent icteric sclera, and yellowing of the face, extending down onto the chest.

In neonates the dermal icterus is first noted in the face and as the bilirubin level rises proceeds caudal to the trunk and then to the extremities.[1]

References

  1. Madlon-Kay, Diane J. Recognition of the Presence and Severity of Newborn Jaundice by Parents, Nurses, Physicians, and Icterometer Pediatrics 1997 100: e3

Template:WH Template:WS